• Users Online: 83
  • Print this page
  • Email this page
Year : 2023  |  Volume : 13  |  Issue : 2  |  Page : 69-73

The cancer genome atlas - TCGA molecular classification: A changing paradigm in the management of endometrial cancers

Gynaecological Oncology Division, Institute of Obstetrics and Gynaecology, Sir Gangaram Hospital, New Delhi, India

Correspondence Address:
Dr. Rahul Deepak Modi
Institute of Obstetrics and Gynaecology - Office, First Floor, OPD Block Building, Sir Gangaram Hospital, Rajinder Nagar, New Delhi - 11060
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/cmrp.cmrp_125_22

Rights and Permissions

Conventionally, endometrial cancers have been risk-stratified as per the clinco-pathological factors. The Cancer Genome Atlas project identified four distinct molecular subtypes within endometrial cancers which further lead to the clinical validation of molecular classification by various research groups. The molecular classification has influenced the risk stratification, thereby impacting adjuvant treatment decisions and prognostication. Molecular classification has paved the precision oncology in gynaecological cancers further strengthening the ongoing advances in targeted therapies and immunotherapy. This review elaborately presents the development of a new molecular classification of endometrial cancers; its evidence-based clinical utility with a brief overview of future perspectives.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded32    
    Comments [Add]    

Recommend this journal